- US-listed companies
- Teladoc Health, Inc.
- Income statement
Teladoc Health, Inc. (TDOC) Income statement
Market cap
$909.82M
P/E ratio
| 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Revenue | 77 | 123 | 233 | 418 | 553 | 1,094 | 2,033 | 2,407 | 2,602 | 2,570 | 2,530 |
| Revenue growth (%) | - | ||||||||||
| Cost of revenue | 21 | 32 | 62 | 129 | 184 | 391 | 650 | 744 | 760 | 751 | 772 |
| Gross profit | 56 | 91 | 172 | 289 | - | - | - | - | - | - | - |
| Gross margin (%) | - | - | - | - | - | - | - | ||||
| Research & development | 14 | 22 | 34 | 54 | 65 | 165 | 312 | 334 | 349 | 307 | 278 |
| Operating margin (%) | |||||||||||
| Operating expenses | - | - | - | - | 634 | 1,600 | 2,298 | 16,060 | 2,851 | 3,590 | 2,793 |
| Operating income | -56 | -63 | -75 | -71 | -80 | -506 | -266 | -13,653 | -249 | -1,021 | -263 |
| Income before tax | -58 | -74 | -107 | -97 | -109 | -576 | -385 | -13,663 | -220 | -994 | -236 |
| Pretax margin (%) | -74.9 | -59.8 | -45.9 | -23.2 | -19.8 | -52.7 | -18.9 | -567.7 | -8.4 | -38.7 | -9.3 |
| Provision for income taxes | 0 | 1 | -0 | 0 | -11 | -91 | 44 | -4 | 1 | 8 | -35 |
| Effective tax rate (%) | |||||||||||
| Net income | -58 | -74 | -107 | -97 | -99 | -485 | -429 | -13,660 | -220 | -1,001 | -200 |
| Net income margin (%) | |||||||||||
| Earnings per share | - | - | - | - | - | - | -2.73 | -84.6 | -1.34 | -5.87 | -1.14 |
| Diluted EPS | - | - | - | - | - | - | -2.73 | -84.6 | -1.34 | -5.87 | -1.14 |
| EBITDA | - | - | - | - | |||||||
| EBITDA margin (%) | - | - | - | - |